Showing results (111-120 of 200) with videos related to
Sort By:
Pageof 20
Postgraduate Medical Journal|November 1, 1987
Malignant cysts of the male breastW S Stebbings, B D George, S Boyle, et al.Acta Neurochirurgica. Supplement|December 28, 2023
VHL: Trends and Insight into a Multi-Modality, Interdisciplinary Approach for Management of Central Nervous System HemangioblastomaS A Matloob, D Paraskevopoulos, S M O'Toole, et al.The British Journal of Ophthalmology|February 1, 1990
Orbital recurrence of retinoblastoma successfully treated by combined therapyR R Goble, J McKenzie, J E Kingston, et al.International Journal of Cancer|April 15, 2011
Prolonged expression of the γ-H2AX DNA repair biomarker correlates with excess acute and chronic toxicity from radiotherapy treatmentEmma C Bourton, Piers N Plowman, Daniel Smith, et al.Journal of Pediatric Hematology/Oncology|July 31, 2004
Thyrotoxicosis after matched unrelated bone marrow transplantationRuth Tatevossian, Jo C Blair, Piers N Plowman, et al.The British Journal of Radiology|December 1, 1989
Periventricular enhancement: a non-pathognomonic sign of intracerebral tumoursP A Murray, A N Harnett, P I Thompson, et al.Orbit (Amsterdam, Netherlands)|December 17, 2008
The use of radiotherapy for the treatment of localized orbital amyloidosisMandip Khaira, Antony Mutamba, George Meligonis, et al.The British Journal of Radiology|August 1, 1990
An instance of clinical radiation morbidity and cellular radiosensitivity, not associated with ataxia-telangiectasiaP N Plowman, B A Bridges, C F Arlett, et al.Eye (London, England)|August 27, 2005
Thyroid orbitopathy possibly predisposes to late-onset of periocular lymphomaC M Nutting, S Shah-Desai, G E Rose, et al.Pediatric Hematology and Oncology|February 5, 1999
Growth hormone deficiency following radiotherapy for orbital and parameningeal sarcomasA G Goddard, S J Harris, P N Plowman, et al.Pageof 20